WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005015220) USE OF PROTEIN CRABP-I AS A MARKER FOR BREAST CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/015220    International Application No.:    PCT/EP2004/008671
Publication Date: 17.02.2005 International Filing Date: 03.08.2004
IPC:
G01N 33/574 (2006.01)
Applicants: ROCHE DIAGNOSTICS GMBH [DE/DE]; Sandhofer Strasse 116, 68305 Mannheim (DE) (DE only).
F. HOFFMANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse 124, CH-4070 Basel (CH) (DE, US only).
PESTLIN, Gabriele [DE/DE]; (DE) (For US Only).
ANDRES, Herbert [DE/DE]; (DE) (For US Only).
BERNDT, Peter [DE/CH]; (CH) (For US Only).
HAGMANN, Marie-Luise [DE/DE]; (DE) (For US Only).
KARL, Johann [DE/DE]; (DE) (For US Only).
LANGEN, Hanno [DE/DE]; (DE) (For US Only).
ZOLG, Werner [DE/DE]; (DE) (For US Only)
Inventors: PESTLIN, Gabriele; (DE).
ANDRES, Herbert; (DE).
BERNDT, Peter; (CH).
HAGMANN, Marie-Luise; (DE).
KARL, Johann; (DE).
LANGEN, Hanno; (DE).
ZOLG, Werner; (DE)
Agent: ROCHE DIAGNOSTICS GMBH; Naser, Werner, Patent Department (TR-E), Postfach 11 52, 82372 Penzberg (DE)
Priority Data:
03017751.3 04.08.2003 EP
Title (EN) USE OF PROTEIN CRABP-I AS A MARKER FOR BREAST CANCER
(FR) UTILISATION DE LA PROTEINE CRABP-I EN TANT QUE MARQUEUR POUR LE CANCER DU SEIN
Abstract: front page image
(EN)The present invention relates to the diagnosis of breast cancer. It discloses the use of protein CRABP-I (cellular retinoic acid-binding protein I) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring CRABP-I in said sample. Measurement of CRABP-I can, e.g., be used in the early detection or detection or diagnosis of breast cancer.
(FR)L'invention concerne le diagnostic du cancer du sein. L'invention concerne l'utilisation de la protéine CRABP-I (protéine I de liaison à l'acide rétinoïque cytoplasmique) dans le diagnostic du cancer du sein. L'invention concerne également une méthode diagnostique du cancer du sein à partir d'un échantillon liquide, dérivé d'un individu par mesure de la protéine CRABP-I dans ledit échantillon. La mesure de la protéine CRABP-I peut, par exemple, être utilisée dans la détection ou le diagnostic précoce d'un cancer du sein.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)